Literature DB >> 15808312

Production of C-reactive protein in Escherichia coli-infected patients with liver dysfunction due to liver cirrhosis.

Wan Beom Park1, Ki-Deok Lee, Chang Seop Lee, Hee Chang Jang, Hong Bin Kim, Hyo-Suk Lee, Myoung-don Oh, Kang Won Choe.   

Abstract

To assess the effect of liver dysfunction on the production of C-reactive protein (CRP), CRP levels were evaluated in patients with Escherichia coli bacteremia with or without liver cirrhosis (LC). Thirty patients of each kind were selected as case and control groups, respectively. A matched control of 30 LC patients without acute infection was also included. In the patients with E. coli bacteremia, median CRP was 6.2 mg/dL (range 0.2-22.1) in the LC patients and 14.6 mg/dL (range 5.8-39.6) in the patients without liver dysfunction (P < 0.001). In the advanced LC patients in Child-Pugh class C, median CRP was 5.0 mg/dL (range 0.2-12.1) in patients with E. coli bacteremia and 0.5 mg/dL (range 0.1-1.2) in patients without acute infection (P < 0.001). Our data suggest that, although CRP levels are reduced in response to acute infection, production is nevertheless maintained even in patients with advanced liver dysfunction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15808312     DOI: 10.1016/j.diagmicrobio.2004.11.014

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  20 in total

1.  Risk factors for mortality in cirrhotic patients with sepsis.

Authors:  Lee-Guan Lim; Xiang-Xuan Eunice Tan; Shu-Jeng Woo; Yock-Young Dan; Yin-Mei Lee; Vincent Lai; Seng-Gee Lim
Journal:  Hepatol Int       Date:  2011-02-13       Impact factor: 6.047

2.  Association between C-reactive protein, incident liver cancer, and chronic liver disease mortality in the Linxian Nutrition Intervention Trials: a nested case-control study.

Authors:  Wen Chen; Jian-Bing Wang; Christian C Abnet; Sanford M Dawsey; Jin-Hu Fan; Liang-Yu Yin; Jian Yin; Philip R Taylor; You-Lin Qiao; Neal D Freedman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-01-22       Impact factor: 4.254

Review 3.  New prognostic markers in liver cirrhosis.

Authors:  Vincent Di Martino; Delphine Weil; Jean-Paul Cervoni; Thierry Thevenot
Journal:  World J Hepatol       Date:  2015-05-28

4.  Ascitic Fluid High Sensitive C-Reactive Protein (hs-CRP). A Prognostic Marker in Cirrhosis with Spontaneous Bacterial Peritonitis.

Authors:  Nakul Kadam; Sourya Acharya; Samarth Shukla; Kriti Gupta
Journal:  J Clin Diagn Res       Date:  2016-04-01

5.  An inhibitor of interleukin-6 trans-signalling, sgp130, contributes to impaired acute phase response in human chronic liver disease.

Authors:  A Lemmers; T Gustot; A Durnez; S Evrard; C Moreno; E Quertinmont; V Vercruysse; P Demetter; D Franchimont; O Le Moine; A Geerts; J Devière
Journal:  Clin Exp Immunol       Date:  2009-06       Impact factor: 4.330

Review 6.  Innate immune cells in liver inflammation.

Authors:  Evaggelia Liaskou; Daisy V Wilson; Ye H Oo
Journal:  Mediators Inflamm       Date:  2012-08-09       Impact factor: 4.711

7.  Usefulness of C-reactive protein for evaluating clinical outcomes in cirrhotic patients with bacteremia.

Authors:  Young Eun Ha; Cheol-In Kang; Eun-Jeong Joo; Mi-Kyong Joung; Doo Ryeon Chung; Kyong Ran Peck; Nam Yong Lee; Jae-Hoon Song
Journal:  Korean J Intern Med       Date:  2011-06-01       Impact factor: 2.884

8.  Synthesis of acute phase proteins in rats with cirrhosis exposed to lipopolysaccharide.

Authors:  Susanne Schouw Nielsen; Thorbjørn Grøfte; Niels Tygstrup; Hendrik Vilstrup
Journal:  Comp Hepatol       Date:  2006-09-12

Review 9.  Management of Infectious Complications Associated with Acute-on-Chronic Liver Failure.

Authors:  Cornelius Engelmann; Thomas Berg
Journal:  Visc Med       Date:  2018-07-27

10.  Use of the delta neutrophil index as a prognostic factor of mortality in patients with spontaneous bacterial peritonitis: implications of a simple and useful marker.

Authors:  Tae Seop Lim; Beom Kyung Kim; Jong Wook Lee; Young Ki Lee; Sooyun Chang; Seung Up Kim; Do Young Kim; Sang Hoon Ahn; Kwang-Hyub Han; Chae Yoon Chon; Jun Yong Park
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.